NDC 0078-0371 – Ritalin LA
Methylphenidate Hydrochloride 30 mg/1 · Capsule, Extended Release · Oral
Product NDC0078-0371
Product details
- Brand name
- Ritalin LA
- Generic name
- Methylphenidate hydrochloride
- Labeler
- Novartis Pharmaceuticals Corporation
- Dosage form
- Capsule, Extended Release
- Route
- Oral
- Marketing category
- NDA · NDA021284
- Marketed since
- June 5, 2002
- Marketing end
- October 31, 2026
- Pharmacologic class
- Central Nervous System Stimulant
Active ingredients
- Methylphenidate Hydrochloride 30 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0078-0371-05 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0078-0371-05) | Jun 5, 2002 |
Other Ritalin products
- 0078-0370 Methylphenidate Hydrochloride 20 mg/1 · Capsule, Extended Release · Novartis Pharmaceuticals Corporation
- 0078-0372 Methylphenidate Hydrochloride 40 mg/1 · Capsule, Extended Release · Novartis Pharmaceuticals Corporation
- 0078-0424 Methylphenidate Hydrochloride 10 mg/1 · Capsule, Extended Release · Novartis Pharmaceuticals Corporation
- 66758-273 Methylphenidate Hydrochloride 5 mg/1 · Tablet · Sandoz Inc
- 66758-274 Methylphenidate Hydrochloride 10 mg/1 · Tablet · Sandoz Inc
- 66758-275 Methylphenidate Hydrochloride 20 mg/1 · Tablet · Sandoz Inc